On the Economic Benefits and Costs of COVID-19 Mitigation Measures in Mexico

29 Pages Posted: 4 May 2020 Last revised: 5 May 2020

Date Written: May 4, 2020

Abstract

In this paper I calculate the daily flows of COVID-19 cases under the current scenario of recommended social distance and restricted economic activity, and under a counterfactual uncontrolled scenario with no mitigation measures. Using official sources, I quantify the supply of hospital beds and ICUs to project the fatality of cases under both scenarios. I estimate that social distance will reduce the number of COVID-19 cases in 65%. The benefits of mitigation measures amount to a reduction of over 119,000 direct fatalities and about 121,000 deaths due to healthcare system overflow. The benefits of these measures are monetized as 697 billion USD. I estimate that the net cost of mitigation in terms of output gap over a 60-months recovery period represents 29% of 2019 Mexico's GDP. This cost would be reduced if a faster recovery occurs or if the government stimulates the economy enough to reduce output gap between the mitigation scenario and the uncontrolled scenario, making a case for an active role of fiscal policies.

Keywords: COVID-19, cost-benefit, epidemic, Mexico

JEL Classification: H12, D16, H42

Suggested Citation

Rojas, Irvin, On the Economic Benefits and Costs of COVID-19 Mitigation Measures in Mexico (May 4, 2020). Available at SSRN: https://ssrn.com/abstract=3592209 or http://dx.doi.org/10.2139/ssrn.3592209

Irvin Rojas (Contact Author)

CIDE

Carretera Mexico Toluca 3655
01210 Mexico, D.F.
Mexico

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
73
Abstract Views
424
rank
347,599
PlumX Metrics